Tisenc Medical

Tisenc is a China-based in vitro diagnostics and medical device company focused on chemiluminescence immunoassay (CLIA) systems, point-of-care testing (POCT), and related diagnostic reagents. Founded in 2015 in Shenzhen, the company develops, manufactures, and commercializes fully automatic CLIA analyzers and matching cartridge-based assays for hospital and laboratory use. Its ACCRE product family is positioned as combining central-lab CLIA performance with POCT-style ease of use across a menu spanning cardiac, inflammatory, endocrine, thyroid, anemia, bone metabolism, diabetes, tumor, and infectious disease markers. Tisenc operates R&D and manufacturing capabilities in China and has promoted global distribution of its diagnostic systems. Since 2022, it has operated as a wholly owned subsidiary of Wondfo Biotech.